Cyril Foa
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 6
- PARP inhibition in cancer therapy 3
-
- Prostate Cancer Treatment and Research 5
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- M. Schneider (4 shared papers)René‐Jean Bensadoun (3 shared papers)Pierre‐Yves Marcy (4 shared papers)F Démard (2 shared papers)Florence Pédeutour (4 shared papers)Nicolas Magné (3 shared papers)M.-N. Falewee (1 shared paper)Jean-Marc Ferrero (6 shared papers)
In The Last Decade
Cyril Foa
30 papers receiving 498 citations
Peers
Comparison fields: 5 of 62
- Otorhinolaryngology 38
- Oncology 151
- Speech and Hearing 35
- Pulmonary and Respiratory Medicine 149
- Obstetrics and Gynecology 33
Countries citing papers authored by Cyril Foa
This map shows the geographic impact of Cyril Foa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Foa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Foa more than expected).
Fields of papers citing papers by Cyril Foa
This network shows the impact of papers produced by Cyril Foa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Foa. The network helps show where Cyril Foa may publish in the future.
Co-authors
The 25 scholars most cited alongside Cyril Foa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 85 | |
| 2 | 2006 | 78 | |
| 3 | 2017 | 54 | |
| 4 | 2003 | 34 | |
| 5 | 2004 | 28 | |
| 6 | 2006 | 28 | |
| 7 | 2001 | 27 | |
| 8 | 2015 | 25 | |
| 9 | 2002 | 23 | |
| 10 | 2000 | 21 | |
| 11 | 2008 | 19 | |
| 12 | 2023 | 12 | |
| 13 | [From cytogenetics to cytogenomics of adipose tissue tumors: 1. Benign adipose tissue tumors]. | 2002 | 12 |
| 14 | 2000 | 11 | |
| 15 | 2001 | 10 | |
| 16 | 2020 | 9 | |
| 17 | [Guillain-Barré syndrome and non-Hodgkin's lymphoma. Report of one case and review of literature]. | 2006 | 6 |
| 18 | 2024 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2001 | 4 |
About Cyril Foa
Cyril Foa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Cardiology and Cardiovascular Medicine and Obstetrics and Gynecology, having authored 32 papers that have together received 516 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Prostate Cancer Treatment and Research (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Breast Cancer Treatment Studies (3 papers), PARP inhibition in cancer therapy (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Otorhinolaryngology (38 citations), Oncology (151 citations), Speech and Hearing (35 citations), Pulmonary and Respiratory Medicine (149 citations) and Obstetrics and Gynecology (33 citations). Cyril Foa has collaborated with scholars based in France, Belgium and Monaco. Frequent co-authors include M. Schneider, René‐Jean Bensadoun, Pierre‐Yves Marcy, F Démard, Florence Pédeutour, Nicolas Magné, M.-N. Falewee, Jean-Marc Ferrero, G. Milano and C Mainguené. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Annals of Oncology, Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.